Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent
ECONOMY & POLICY

Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.

The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.

The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.

Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.

For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Next Story
Infrastructure Urban

Smartworks Leases Over 400 Seats In Mumbai To Japanese NBFC Subsidiary

Smartworks has leased over 400 seats at its Mumbai centre to a subsidiary of a Japanese non-bank finance company in a Rs 350 million (mn) transaction. The company said the agreement covers managed office space designed to support the tenant's India operations and will strengthen its presence in the city. The deal was presented as part of Smartworks' strategy to grow its enterprise client base. The leased seating forms part of a larger workplace solution that combines private offices and flexible seating tailored to financial services clients. Smartworks noted that demand from the banking, fina..

Next Story
Infrastructure Energy

Aequs SEZ Nears Complete Green Power Adoption

Aequs Infra's Belagavi special economic zone has moved close to complete renewable energy adoption for on-site industrial operations. Energy requirements within the cluster are met through a combination of rooftop solar installations, open access renewable energy procured from third-party providers and green power supplied by the state electricity board. The integrated approach has enabled the campus to sustain operational reliability while advancing environmental objectives. The licensed power distribution network within the campus supports stable energy delivery and creates economic benefits..

Next Story
Infrastructure Energy

Waaree Secures EPC Order For 300 MW Solar Project

Waaree Renewable Technologies (Waaree) has signed a Letter of Award with its wholly owned subsidiary, Sunsational Power Private (SPPL), to develop a 300 megawatt (MW) and 450 megawatt peak (MWp) ground-mounted solar project. The company will provide engineering, procurement and construction services and two-year operation and maintenance services under the contract. The agreement covers the full EPC scope and a two-year O&M commitment. The scope will include site engineering, procurement of equipment and construction management across the installation. The project is scheduled to be completed ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement